z-logo
open-access-imgOpen Access
Artificial Intelligence Based on Blood Biomarkers Including CTCs Predicts Outcomes in Epithelial Ovarian Cancer: A Prospective Study
Author(s) -
Jun Ma,
Jiani Yang,
Yue Jin,
Shanshan Cheng,
Shan Huang,
Nan Zhang,
Yu Wang
Publication year - 2021
Publication title -
oncotargets and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.054
H-Index - 60
ISSN - 1178-6930
DOI - 10.2147/ott.s307546
Subject(s) - machine learning , random forest , circulating tumor cell , receiver operating characteristic , artificial intelligence , naive bayes classifier , medicine , oncology , logistic regression , proportional hazards model , ovarian cancer , support vector machine , cancer , computer science , metastasis
We aimed to develop an ovarian cancer-specific predictive framework for clinical use platinum-sensitivity and prognosis using machine learning methods based on multiple biomarkers, including circulating tumor cells (CTCs).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here